Header Logo

ADDISON TAYLOR

TitleProfessor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
AddressOne Baylor Plaza
vCardDownload vCard
    Other Positions
    TitleProfessor
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Biochemistry and Molecular Pharmacology
    DivisionBiochemistry & Mol Pharmacology


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Jia X, Nambi V, Berry JD, Dalmacy D, Ascher SB, Taylor AA, Hoogeveen RC, de Lemos JA, Ballantyne CM. High-Sensitivity Cardiac Troponins I and T and Cardiovascular Outcomes: Findings from the Systolic Blood Pressure Intervention Trial (SPRINT). Clin Chem. 2024 02 07; 70(2):414-424. PMID: 38084941.
      Citations:    Fields:    Translation:Humans
    2. Ishani A, Cushman WC, Leatherman SM, Lew RA, Woods P, Glassman PA, Taylor AA, Hau C, Klint A, Huang GD, Brophy MT, Fiore LD, Ferguson RE, Diuretic Comparison Project Writing Group. Chlorthalidone vs. Hydrochlorothiazide for Hypertension-Cardiovascular Events. N Engl J Med. 2022 12 29; 387(26):2401-2410. PMID: 36516076.
      Citations:    
    3. Ishani A, Leatherman SM, Woods P, Hau C, Klint A, Lew RA, Taylor AA, Glassman PA, Brophy MT, Fiore LD, Ferguson RE, Cushman WC. Design of a pragmatic clinical trial embedded in the Electronic Health Record: The VA's Diuretic Comparison Project. Contemp Clin Trials. 2022 05; 116:106754. PMID: 35390512.
      Citations:    
    4. Triska J, Bozkurt B, Elkayam U, Taylor A, Birnbaum Y, Tamargo J. An Updated Review on the Role of Non-dihydropyridine Calcium Channel Blockers and Beta-blockers in Atrial Fibrillation and Acute Decompensated Heart Failure: Evidence and Gaps. Cardiovasc Drugs Ther. 2023 Dec; 37(6):1205-1223. PMID: 35357604.
      Citations:    Fields:    
    5. Cochran JM, Siebert VR, Bates J, Butulija D, Kolpakchi A, Kadiyala H, Taylor A, Jneid H. The Relationship between Adult Height and Blood Pressure. Cardiology. 2021; 146(3):345-350. PMID: 33721862.
      Citations: 2     Fields:    Translation:Humans
    6. Juraschek SP, Hu JR, Cluett JL, Ishak A, Mita C, Lipsitz LA, Appel LJ, Beckett NS, Coleman RL, Cushman WC, Davis BR, Grandits G, Holman RR, Miller ER, Peters R, Staessen JA, Taylor AA, Thijs L, Wright JT, Mukamal KJ. Effects of Intensive Blood Pressure Treatment on Orthostatic Hypotension : A Systematic Review and Individual Participant-based Meta-analysis. Ann Intern Med. 2021 01; 174(1):58-68. PMID: 32909814; PMCID: PMC7855528.
      Citations:    
    7. Gillette M, Taylor A, Butulija D, Kadiyala H, Jneid H. Reflections of the Angiotensin Receptor Blocker Recall by the FDA and Repercussions on Healthcare. Cardiovasc Drugs Ther. 2020 08; 34(4):579-584. PMID: 32318933; PMCID: PMC7171054.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    8. Juraschek SP, Taylor AA, Wright JT, Evans GW, Miller ER, Plante TB, Cushman WC, Gure TR, Haley WE, Moinuddin I, Nord J, Oparil S, Pedley C, Roumie CL, Whittle J, Wiggers A, Finucane C, Anne Kenny R, Appel LJ, Townsend RR, SPRINT Research Group. Orthostatic Hypotension, Cardiovascular Outcomes, and Adverse Events: Results From SPRINT. Hypertension. 2020 Mar; 75(3):660-667. PMID: 31983312.
      Citations:    
    9. Cho ME, Craven TE, Cheung AK, Glasser SP, Rahman M, Soliman EZ, Stafford RS, Johnson KC, Bates JT, Burgner A, Taylor AA, Tamariz L, Tang R, Beddhu S, SPRINT Study Research Group. The association between insulin resistance and atrial fibrillation: A cross-sectional analysis from SPRINT (Systolic Blood Pressure Intervention Trial). J Clin Hypertens (Greenwich). 2017 Nov; 19(11):1152-1161. PMID: 28866864.
      Citations:    
    10. Drawz PE, Pajewski NM, Bates JT, Bello NA, Cushman WC, Dwyer JP, Fine LJ, Goff DC, Haley WE, Krousel-Wood M, McWilliams A, Rifkin DE, Slinin Y, Taylor A, Townsend R, Wall B, Wright JT, Rahman M. Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure Study. Hypertension. 2017 01; 69(1):42-50. PMID: 27849563; PMCID: PMC5145774.
      Citations: 68     Fields:    Translation:Humans
    11. Townsend RR, Chang TI, Cohen DL, Cushman WC, Evans GW, Glasser SP, Haley WE, Olney C, Oparil S, Del Pinto R, Pisoni R, Taylor AA, Umanath K, Wright JT, Yeboah J, SPRINT Study Research Group. Orthostatic changes in systolic blood pressure among SPRINT participants at baseline. J Am Soc Hypertens. 2016 11; 10(11):847-856. PMID: 27665708; PMCID: PMC5344034.
      Citations:    
    12. Tamura MK, Pajewski NM, Bryan RN, Weiner DE, Diamond M, Van Buren P, Taylor A, Beddhu S, Rosendorff C, Jahanian H, Zaharchuk G, SPRINT Study Research Group. Chronic kidney disease, cerebral blood flow, and white matter volume in hypertensive adults. Neurology. 2016 Mar 29; 86(13):1208-16. PMID: 26920359; PMCID: PMC4818564.
      Citations: 23     Fields:    Translation:Humans
    13. Brunner G, Bismuth J, Nambi V, Ballantyne CM, Taylor AA, Lumsden AB, Morrisett JD, Shah DJ. Calf muscle perfusion as measured with magnetic resonance imaging to assess peripheral arterial disease. Med Biol Eng Comput. 2016 Nov; 54(11):1667-1681. PMID: 26906279; PMCID: PMC5152942.
      Citations: 8     Fields:    Translation:Humans
    14. Chang TI, Evans G, Cheung AK, Cushman WC, Diamond MJ, Dwyer JP, Huan Y, Kitzman D, Kostis JB, Oparil S, Rastogi A, Roumie CL, Sahay R, Stafford RS, Taylor AA, Wright JT, Chertow GM, SPRINT Study Research Group. Patterns and Correlates of Baseline Thiazide-Type Diuretic Prescription in the Systolic Blood Pressure Intervention Trial. Hypertension. 2016 Mar; 67(3):550-5. PMID: 26865200; PMCID: PMC4755350.
      Citations:    
    15. Ababneh B, Rejjal L, Pokharel Y, Nambi V, Wang X, Tung CH, Han RI, Taylor AA, Kougias P, Lumsden AB, Lawrie G, Reardon M, Ballantyne CM, Morrisett JD, Brunner G. Distribution of calcification in carotid endarterectomy tissues: comparison of micro-computed tomography imaging with histology. Vasc Med. 2014 Oct; 19(5):343-50. PMID: 25193489.
      Citations: 3     Fields:    Translation:Humans
    16. Brunner G, Yang EY, Kumar A, Sun W, Virani SS, Negi SI, Murray T, Lin PH, Hoogeveen RC, Chen C, Dong JF, Kougias P, Taylor A, Lumsden AB, Nambi V, Ballantyne CM, Morrisett JD. The Effect of Lipid Modification on Peripheral Artery Disease after Endovascular Intervention Trial (ELIMIT). Atherosclerosis. 2013 Dec; 231(2):371-7. PMID: 24267254; PMCID: PMC4545656.
      Citations: 10     Fields:    Translation:Humans
    17. White CL, Pergola PE, Szychowski JM, Talbert R, Cervantes-Arriaga A, Clark HD, Del Brutto OH, Godoy IE, Hill MD, Pelegrí A, Sussman CR, Taylor AA, Valdivia J, Anderson DC, Conwit R, Benavente OR, SPS3 Investigators. Blood pressure after recent stroke: baseline findings from the secondary prevention of small subcortical strokes trial. Am J Hypertens. 2013 Sep; 26(9):1114-22. PMID: 23736109; PMCID: PMC3816319.
      Citations:    
    18. Yang EY, Brunner G, Dokainish H, Hartley CJ, Taffet G, Lakkis N, Taylor AA, Misra A, McCulloch ML, Morrisett JD, Virani SS, Ballantyne CM, Nagueh SF, Nambi V. Application of speckle-tracking in the evaluation of carotid artery function in subjects with hypertension and diabetes. J Am Soc Echocardiogr. 2013 Aug; 26(8):901-909.e1. PMID: 23759168; PMCID: PMC3725197.
      Citations: 6     Fields:    Translation:Humans
    19. Taylor AA, Ragbir S. Three in one: safety, efficacy, and patient acceptability of triple fixed-dose combination medicine in the management of hypertension. Patient Prefer Adherence. 2012; 6:555-63. PMID: 22927748; PMCID: PMC3422120.
      Citations:    
    20. Cowart JB, Taylor AA. Should two-drug initial therapy for hypertension be recommended for all patients? Curr Hypertens Rep. 2012 Aug; 14(4):324-32. PMID: 22661332.
      Citations:    
    21. Wong WW, Taylor AA, Smith EO, Barnes S, Hachey DL. Effect of soy isoflavone supplementation on nitric oxide metabolism and blood pressure in menopausal women. Am J Clin Nutr. 2012 Jun; 95(6):1487-94. PMID: 22552034; PMCID: PMC3349458.
      Citations: 7     Fields:    Translation:HumansAnimals
    22. Taylor AA, Pool JL. Clinical role of direct renin inhibition in hypertension. Am J Ther. 2012 May; 19(3):204-10. PMID: 21317620.
      Citations: 2     Fields:    Translation:Humans
    23. Taylor AA, Siragy H, Nesbitt S. Angiotensin receptor blockers: pharmacology, efficacy, and safety. J Clin Hypertens (Greenwich). 2011 Sep; 13(9):677-86. PMID: 21896150; PMCID: PMC8108884.
      Citations: 23     Fields:    Translation:Humans
    24. Balasubramanyam A, Coraza I, Smith EO, Scott LW, Patel P, Iyer D, Taylor AA, Giordano TP, Sekhar RV, Clark P, Cuevas-Sanchez E, Kamble S, Ballantyne CM, Pownall HJ. Combination of niacin and fenofibrate with lifestyle changes improves dyslipidemia and hypoadiponectinemia in HIV patients on antiretroviral therapy: results of "heart positive," a randomized, controlled trial. J Clin Endocrinol Metab. 2011 Jul; 96(7):2236-47. PMID: 21565796; PMCID: PMC3135191.
      Citations: 26     Fields:    Translation:Humans
    25. Taylor AA. Leadership message. ASH hypertension community outreach. J Clin Hypertens (Greenwich). 2010 Jul 01; 12(7):527-8. PMID: 20629817; PMCID: PMC8673071.
      Citations: 1     Fields:    Translation:Humans
    26. Taylor AA, Bakris GL. The role of vasodilating beta-blockers in patients with hypertension and the cardiometabolic syndrome. Am J Med. 2010 Jul; 123(7 Suppl 1):S21-6. PMID: 20609696.
      Citations:    
    27. Puig JG, Schunkert H, Taylor AA, Boye S, Jin J, Keefe DL. Evaluation of the dose--response relationship of aliskiren, a direct renin inhibitor, in an 8-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled study in adult patients with stage 1 or 2 essential hypertension. Clin Ther. 2009 Dec; 31(12):2839-50. PMID: 20110023.
      Citations:    
    28. Barranco E, Gorostidi M, Taylor A, Zhang X, Xiang Z, Zhang J, Geiger H. Combination therapy with various combinations of aliskiren, valsartan, and hydrochlorothiazide in hypertensive patients not adequately responsive to hydrochlorothiazide alone. J Clin Hypertens (Greenwich). 2009 Jun; 11(6):324-32. PMID: 19527323; PMCID: PMC8673065.
      Citations: 14     Fields:    Translation:Humans
    29. White WB, Calhoun DA, Samuel R, Taylor AA, Zappe DH, Purkayastha D. Improving blood pressure control: increase the dose of diuretic or switch to a fixed-dose angiotensin receptor blocker/diuretic? the valsartan hydrochlorothiazide diuretic for initial control and titration to achieve optimal therapeutic effect (Val-DICTATE) trial. J Clin Hypertens (Greenwich). 2008 Jun; 10(6):450-8. PMID: 18550935.
      Citations:    
    30. Uresin Y, Taylor AA, Kilo C, Tschöpe D, Santonastaso M, Ibram G, Fang H, Satlin A. Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension. J Renin Angiotensin Aldosterone Syst. 2007 Dec; 8(4):190-8. PMID: 18205098.
      Citations:    
    31. Yang CY, Chen HH, Huang MT, Raya JL, Yang JH, Chen CH, Gaubatz JW, Pownall HJ, Taylor AA, Ballantyne CM, Jenniskens FA, Smith CV. Pro-apoptotic low-density lipoprotein subfractions in type II diabetes. Atherosclerosis. 2007 Aug; 193(2):283-91. PMID: 17030034.
      Citations: 12     Fields:    Translation:HumansAnimalsCells
    32. Taylor AA, Pool JL. Clinical pharmacology of antihypertensive therapy. Semin Nephrol. 2005 Jul; 25(4):215-26. PMID: 16202694.
      Citations: 1     Fields:    Translation:Humans
    33. Taylor AA. Combination drug treatment of hypertension: have we come full circle? Curr Cardiol Rep. 2004 Nov; 6(6):421-6. PMID: 15485601.
      Citations:    
    34. Motil KJ, Allen J, Taylor A. When a research subject calls with a complaint, what will the institutional review board do? IRB. 2004 Jan-Feb; 26(1):9-13. PMID: 15281212.
      Citations: 1     Fields:    Translation:Humans
    35. Taylor AA, Shoheiber O. Adherence to antihypertensive therapy with fixed-dose amlodipine besylate/benazepril HCl versus comparable component-based therapy. Congest Heart Fail. 2003 Nov-Dec; 9(6):324-32. PMID: 14688505.
      Citations:    
    36. Yang CY, Raya JL, Chen HH, Chen CH, Abe Y, Pownall HJ, Taylor AA, Smith CV. Isolation, characterization, and functional assessment of oxidatively modified subfractions of circulating low-density lipoproteins. Arterioscler Thromb Vasc Biol. 2003 Jun 01; 23(6):1083-90. PMID: 12689919.
      Citations: 32     Fields:    Translation:HumansAnimalsCells
    37. Malave HA, Taylor AA, Nattama J, Deswal A, Mann DL. Circulating levels of tumor necrosis factor correlate with indexes of depressed heart rate variability: a study in patients with mild-to-moderate heart failure. Chest. 2003 Mar; 123(3):716-24. PMID: 12628868.
      Citations: 21     Fields:    Translation:Humans
    38. White WB, Kent J, Taylor A, Verburg KM, Lefkowith JB, Whelton A. Effects of celecoxib on ambulatory blood pressure in hypertensive patients on ACE inhibitors. Hypertension. 2002 Apr; 39(4):929-34. PMID: 11967252.
      Citations: 30     Fields:    Translation:HumansCTClinical Trials
    TAYLOR's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (202)
    Explore
    _
    Co-Authors (22)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _